Figure 1.

Reduced expression of PKD1 and cell viability in BM‐MSCs treated with H₂O₂. Primary rat BM‐MSCs were treated with 0–400 µM H₂O₂. (A) Cell viability was measured using CCK8. (B) FDA was used to fluorescently label BM‐MSCs. (C) Western blot analysis was performed to measure the protein expression of PKD1. (D) qPCR was performed to measure the mRNA expression of PKD1. Data were expressed as the mean ± SD, n = 3. *p < .05, **p < .01 versus 0 µM H₂O₂‐treated cells. BM‐MSCs, bone marrow‐mesenchymal stem cells; FDA, Food and Drug Administration; mRNA, messenger RNA; qPCR, quantitative polymerase chain reaction